InvestorsHub Logo

MI Dendream

02/10/22 7:40 AM

#442804 RE: Reefrad #442803

Maybe he is talking about breast cancer in men. Those numbers are similar to GBM.

Rare disease…different views about a drug candidate (and premarket promotion) from within and without.

dennisdave

02/10/22 7:45 AM

#442808 RE: Reefrad #442803

that is an odd way of comparing market size, the rarity of the disease.
I did not assert that the number of GBM patients is as high as women with breast cancer which is also odd to look at it.

Treating a patient with GBM is way more expensive and has a higher price than treating a patient with breast cancer resulting in approx the same market revenue. In other words 10,000 x 10 is the same as 100 x 1000